Atrial fibrillation (AF) is the most common supraventricular cardiac arrhythmia in the general population, and its prevalence increases with both age and comorbidities [1].
https://t.co/JE6JRCWan0
Gender-related disparities in access to medical care,
clinical presentation, therapy, and outcomes have been
highlighted by numerous studies
https://t.co/YJ2AAXwaYG
We present a case of a 70-year-old man with a medical history of exacerbated coronary artery disease, arterial hypertension, diabetes mellitus and hypercholesterolemia.
https://t.co/DINHdLP3tV
The idea to directly implant cardiomyocytes into the injured area was initially tested in animal models. Contrary to adult cardiomyocytes, which did not survive under any conditions, fetal and neonatal cells formed new and mature myocardium in inbred rats.
https://t.co/e9hgoU2D1E
Percutaneous coronary intervention (PCI) for calcified lesions poses risks of major adverse cardiac events (MACE), increased radiation exposure, and contrast use for patients.
https://t.co/Nid6bQOoTc
Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to significant morbidity and mortality.
https://t.co/c9vrAe62XJ
Transcatheter aortic valve implantation (TAVI) is the treatment of choice for severe aortic stenosis in elderly and high-risk patients; however, long-term mortality remains substantial.
https://t.co/FMjI4uOtAH
The new Journal Impact Factor (JIF) of 2.0 for Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej is an important milestone for the journal and for its authors, reviewers, readers, and the wider interventional cardiology community.
https://t.co/OZuHBgCZiF
The use of intravascular imaging during percutaneous coronary intervention (PCI) has been shown to have a significant positive impact on clinical outcomes.
https://t.co/V50kxJUA8B
Transcatheter aortic valve implantation (TAVI) is the treatment of choice for severe aortic stenosis in elderly and high-risk patients; however, long-term mortality remains substantial.
https://t.co/FMjI4uNVL9
Percutaneous coronary intervention (PCI) for calcified lesions poses risks of major adverse cardiac events (MACE), increased radiation exposure, and contrast use for patients.
https://t.co/Nid6bQNR3E
Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the pulmonary arteries, leading to significant morbidity and mortality.
https://t.co/c9vrAe5v8b
Data on the change in mitral valve annulus diameter (MAD), and left atrial appendage (LAA) structure and function after transcatheter edge-to-edge repair (TEER) of the mitral valve in patients with secondary mitral regurgitation (MR) are lacking.
https://t.co/ANqK8V5nKw